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Interleukin-18 is a potent inducer of interferon-g by keratinocyte-secreted interleukin-18 is biologically
active, in that conditioned media from phorbol 12-activated T cells, macrophages, and monocytes and is
synthesized as an inactive precursor. Pro-interleukin- myrisate 13-acetate, lipopolysaccharide and DNCB-
treated human keratinocytes induce interferon-g18 must be cleaved by interleukin-1-b-converting
enzyme for secretion of the biologically active form. expression by peripheral blood mononuclear cells.
This bioactivity is neutralized by anti-interleukin-18,We report that among selected non-bone marrow
derived skin cells, interleukin-18 mRNA is constitu- but not anti-interleukin-12 antibodies. By immuno-
histochemistry, interleukin-18 protein is detected intively expressed by human keratinocytes and not by
dermal microvascular endothelial cells, dermal basal keratinocytes of normal human skin, but its
expression is markedly upregulated in suprabasalfibroblasts, or melanocytes. Interleukin-18 mRNA and
intracellular protein levels are neither changed in keratinocytes in psoriasis. These findings indicate that
human keratinocytes are a source of biologically func-human keratinocytes nor induced in human dermal
microvascular endothelial cells, dermal fibroblasts, tional interleukin-18 and thus are capable of playing
an initiating part in the local interferon-g-dependentor melanocytes by exposure to pro-inflammatory
stimuli. Exposure of human keratinocytes to phorbol inflammatoryprocesses through expression, activation,
and secretion of interleukin-18. Key words: cytokines/12-myrisate 13-acetate, lipopolysaccharides or the
contact sensitizer DNCB results in the secretion of inflammation/skin/Th1/Th2. J Invest Dermatol 113:766–
772, 1999immunoprecipitable interleukin-18 protein. Human
T as IFN-γ-inducing factor (IGIF), is a potent inducer of IFN-γby activated T cells (Okamura et al, 1995). Since its initialcharacterization, IL-18 has been found to have multiple othereffects upon various cells involved in the inflammatory response(Okamura et al, 1995; Tsutsui et al, 1996; Ushio et al, 1996; Purenhe epidermal tissue of the skin is the first line ofdefense against exposure to physical, microbial, andchemical agents that cause local cellular injury(Kupper, 1990; Kalish, 1995). During the evolutionof an inflammatory response, leukocyte subsets are
recruited and extravasate through the locally modified endothelium, et al, 1998). IL-12 and IL-18 play important parts in the development
a process that is orchestrated by local cytokine production (Springer, of T helper type 1 (Th1) cells (Okamura et al, 1995) and are
1995; Ebnet et al, 1996). The activation of macrophages and T synergistic in the induction of IFN-γ by T cells (Okamura et al,
lymphocytes during the inflammatory responses elicits a con- 1995; Robinson et al, 1997).
comitant release of cytokines by these cells, including interferon IL-18 exhibits an IL-1 signature-like sequences (Ushio et al,
(IFN)-γ (Romagnani, 1994). 1996) and contains trefoil structures similar to the IL-1 family of
The newly described cytokine interleukin (IL-18), also known cytokines (Murzin et al, 1992; Bazan et al, 1996). IL-18 and IL-1,
however, share only 15–18% homology at the amino acid level
and exhibit different biologic activities that are transmitted through
specific receptors (Parnet et al, 1996; Matsumoto et al, 1997;Manuscript received April 7, 1999; revised June 30, 1999; accepted for
publication July 22, 1999 Robinson et al, 1997; Torigoe et al, 1997; Dinarello et al, 1998).
Reprint requests to: Emory Skin Diseases Research Core Center, The murine (Okamura et al, 1995) and human IL-18 (Ushio et al,
Department of Dermatology, 5001 Woodruff Memorial Bldg., Emory 1996) cDNA share a 65% homology. Human IL-18 (hIL-18) is
University School of Medicine, Atlanta, GA 30322, U.S.A. Email: synthesized as an inactive precursor form (pro-hIL-18) of 23 kDascaughm@emory.edu
that does not contain a known signal peptide sequence (OkamuraAbbreviations: HDMEC, human dermal microvascular endothelial
et al, 1995). Like the activation of IL-1β (Thornberry et al,cells; HDF, human dermal fibroblasts; HM, human melanocytes; ICE,
1992), murine pro-IL-18 has been shown to be activated byinterleukin-1β converting enzyme; PBMC, peripheral blood mono-
nuclear cells. IL-1β-converting enzyme (ICE or Caspase 1) by cleavage at the
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(LPS), dimethylsulfoxide (DMSO), or 0.001% DNCB in DMSO (all fromN-term-Asp35 to secrete a biologically functional form of 18.8 kDa
Sigma) for 16 h. Ten micrograms of total cellular RNA isolated from(Ghayur et al, 1997; Gu et al, 1997).
treated or untreated cells was analyzed by northern blot using either humanTo date IL-18 has been reported to be produced by activated
IL-18 or β-actin cDNA as probes and were subjected to autoradiographymacrophages such as Kupffer cells, monocytes (Okamura et al,
on X-OMAT film (Eastman Kodak Co., Rochester, NY). The human IL-1995; Ushio et al, 1996), osteoblasts (Udagawa et al, 1997), and 18 cDNA was generated by reverse transcription–polymerase chain reaction
dendritic and Langerhans cells (Stoll et al, 1998) in addition to T from PBMC total RNA using primers corresponding to the nucleotides
cells. Non-bone marrow derived cells of the skin have been 178–201 (59-ATGGCTGCTGAACCAGTAGAAGAC-39) and 735–759
shown to express a wide array of pro-inflammatory cytokines either (59-CTAGTCTTCGTTTTGAACAGTGAAC-39) of the published hIL-
18 cDNA (Okamura et al, 1995) using the Superscript pre-amplificationconstitutively or after a variety of stimuli (Kupper, 1990; Luger
system (Life Technologies, Inc.) according to the manufacturer’s protocol.and Schwarz, 1990). Consequently, we investigated the profile of
IL-18 cDNA amplified by reverse transcription–polymerase chain reactionIL-18 expression in cultured human cutaneous cells, including
from total PBMC RNA was sequenced to confirm identity with thekeratinocytes, dermal microvascular endothelial cells (HDMEC),
published hIL-18 cDNA sequence (Okamura et al, 1995) and used todermal fibroblasts (HDF), and melanocytes (HM). Several significant
probe northern blots.reports related to the expression of ICE and bioactive IL-18
prompted us to investigate the effects of pro-inflammatory sub-
Polyribosome profile analysis Polysome fractions were obtained asstances on the expression of IL-18 in human keratinocytes, described (Rogers and Munro, 1987; Caruccio and Ross, 1994; Schalinske
HDMEC, HDF, and HM. These reports included secretion of IL- et al, 1998). In brief, whole cell lysates were prepared from untreated
1β in response to urushiol (the immunogenic moiety of poison human keratinocyte cells (1 3 107 cells) by scraping the cells in 500 µl of
ivy) via activation by ICE (Boehm et al, 1996; Zepter et al, 1997), ice-cold lysis buffer comprised of 150 mM KCl, 10 mM MgCl2, 150 mg
modulation of ICE by activators and inhibitors of protein kinase cycloheximide per ml, 0.5 mg heparin per ml (all from Sigma), 10 mM
Tris–Cl (pH 7.2) (Life Technologies, Inc.), 20 mM DTT, 0.5% NP-40 (allC such as phorbol 12-myristate 13-acetate (PMA) and 1-(5-
from United States Biochemical Corp., Cleveland, OH), and 100 Uisoquinolinylsulfonyl)-2-methylpiperazine (Zepter et al, 1997), and
RNAsin per ml (Promega Corp., Madison, WI) using diethylpyro-production of bioactive IL-18 by murine keratinocytes (Stoll
carbonate (Sigma) treated and autoclaved water. Cells were left on ice foret al, 1997).
10 min and then centrifuged for 10 min at 735 3 g to separate nuclei.We report that among the non-bone marrow derived cells of Supernatants were stored on ice. A linear 10–60% (by weight) sucrose
the skin, only human keratinocytes constitutively express IL- gradient was poured in 12 ml Beckman poly-allomer tubes (14 3 89 mm)
18 mRNA and protein. On exposure to selected inflammatory containing ultra-pure sucrose (Life Technologies, Inc.) in 20 mM HEPES
mediators and the contact sensitizer DNCB IL-18 mRNA levels (pH 7.2), 250 mM KCl, 10 mM MgCl2, 20 mM DTT, 150 µg cycloheximide
were not modulated further in human keratinocytes or induced per ml, 0.5 µg heparin per ml, and 10 U RNAsin per ml. A 50 µl aliquot
of the post-nuclear human keratinocyte supernatant was saved as a controlde novo in HDMEC, HDF, or HM. In addition, upon treatment
and the remainder was applied gently on to the linear sucrose gradient andwith pro-inflammatory mediators and DNCB, human keratinocytes
centrifuged at 110,000 3 g in a swinging bucket rotor for 4 h at 4°C.secrete biologically active IL-18 that is capable of inducing IFN-γ
Total RNA was isolated from the unfractionated control sample and fromproduction by human peripheral blood mononuclear cells (PBMC).
1.25 ml fractions that were collected from the gradient. The RNA samplesImmunohistochemical studies reveal that IL-18 protein is constitu- were then analyzed for the presence of IL-18 mRNA by northern blot.
tively expressed in basal keratinocytes in normal human skin and
that its expression is markedly increased in suprabasal keratinocytes Immunoprecipitation and western blot analysis Equal amounts ofin psoriasis. These studies thus demonstrate that keratinocyte- total protein (50 µg) from treated or untreated cells were analyzed by
derived IL-18 may play an important part in IFN-γ-dependent and western blot analysis. Polyclonal N-terminal or C-terminal anti-human
T cell-mediated inflammation in the skin. IL-18 antibodies (Research Diagnostics Inc., NJ) at a 1:100 dilution and
donkey–anti-goat IgG horseradish peroxidase-conjugated antibodies (Santa
MATERIALS AND METHODS Cruz Biotechnology Inc., Santa Cruz, CA) at a 1:1500 dilution were used
as primary and secondary antibodies respectively. Actin was used as anCell culture Human PBMC, isolated as previously described (Kanof
internal protein standard for loading control and was detected by mouseet al, 1991) and THP.1, a human monocytic cell line (ATCC, Rockville,
anti-actin (Chemicon International, Inc., Temecula, CA) primary antibodiesMD), were cultured in RPMI-1640 media containing 10 mM HEPES,
at a 1:1000 dilution and goat anti-mouse Ig (BioRad) at 1:5000 dilution.1 mM sodium pyruvate, 2 mM L-glutamine, 4500 mg glucose per l and
Equal volumes of cell culture supernatants were used with anti-IL-181500 mg sodium bicarbonate per l (Vita Cell, ATCC). PBMC were
antibodies at a concentration of 2 µg per ml for immunoprecipitation bysupplemented with 10% human serum (Irvine Scientific, Santa Ana, CA)
standard methods, except using a modified immunoprecipitation bufferand THP.1 with 10% fetal bovine serum (Atlanta Biologicals Inc., Norcross,
containing 1% Triton X-100, 150 mM NaCl, 10 mM Tris (pH 7.4), 1 mMGA). Human keratinocytes, HM, HDMEC, and HDF were isolated from
ethylenediamine tetraacetic acid, 2 mM ethyleneglycol-bis(β-aminoethylneonatal foreskins at the Emory Skin Diseases Research Core Center as
ether)-N,N,N9,N9-tetraacetic acid, 0.2 mM Na3VO4, 0.2 mM phenyl-previously described (Boyce and Ham, 1985; Kubota et al, 1988). Human
methylsulfonyl fluoride, and 0.5% NP-40. The immunoprecipitated pro-keratinocytes were cultured in keratinocyte growth media supplemented
teins were subjected to a western blot analysis using anti-IL-18 antibodieswith bovine pituitary extract (Clonetics, Walkersville, MD). HDMEC
or an irrelevant control antibody. Blots were developed using the chemi-were cultured in MCDB 131 media (Life Technologies, Inc., Grand Island,
luminescent detection reagent ECL (Amersham Life Science Inc.) andNY) supplemented with 30% normal human serum (Irvine Scientific),
exposed to X-OMAT film (Eastman Kodak Co.) to obtain a fluorograph.N 6,29-O-dibutyryl-cyclic adenosine monophosphate (5 3 10–5 M; Sigma),
100 U per ml penicillin, 0.25 mg per ml amphotericin B, and 10 µg per
ml streptomycin (all from Life Technologies, Inc.). HM were cultured in Immunohistochemistry Paraffin-embedded tissue sections of 4 µm
thickness from biopsied human psoriatic lesions and normal skin wereMelanocyte Growth Medium Bulletkit (Clonetics). HDF were cultured in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 3 mM used after deparaffinization and rehydration according to the standard
protocol (Jaffe and Raffeld, 1996). Sections were fixed in 0.4% formalde-L-glutamine, 100 U per ml penicillin, 0.25 mg per ml amphotericin B,
and 10 µg per ml streptomycin (all from Life Technologies, Inc.), and 10% hyde and immersed in 0.1 M Na-citrate (Sigma) at 100°C for 1 min for
antigen unmasking. The tissue sections were subjected to peroxidasefetal bovine serum (Hy-Clone Laboratories Inc., Logan, UT). Cell cultures
were maintained at 37°C in humidified incubators with 5% CO2. Human immunostaining using VectaStain elite ABC kit (Vector Laboratories Inc.,
Burlingame, CA) according to the manufacturer’s recommendations.keratinocytes were passaged at 60–70% confluence to avoid differentiation,
using subculture reagents (Clonetics). Experiments with primary cells Normal rabbit serum from the VectaStain kit was used to avoid nonspecific
binding of the secondary biotinylated antibody. Normal goat serum(human keratinocytes, HM, HDMEC, and HDF) were conducted with
subconfluent cells at passage 3. (Accurate Chemical & Scientific Corp., Westbury, CT) was used as a first
step negative control and goat–anti-human IL-18 or goat–anti-human ICE
(p20 subunit) antibodies (all from Research Diagnostics Inc.) were used asNorthern blot analysis This was performed for IL-18 mRNA levels
after treatment of cells with a variety of pro-inflammatory mediators. primary antibodies at a 1:20 dilution. The primary antibodies were detected
using biotinylated rabbit–anti-goat secondary antibodies and a preformedThese mediators were added directly to cells after a fresh media change
and consisted of 10 ng per ml PMA, 50 ng per ml lipopolysaccharide avidin and biotinylated horseradish peroxidase complex from the VectaStain
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elite ABC kit. Sections were stained with the AEC substrate (Vector
Laboratories Inc.), counterstained with Mayer’s hematoxylin, coverslipped
and photographed with an Olympus C35AD-4 camera, mounted on an
Olympus BH2 microscope.
IFN-g enzyme-linked immunosorbent assay (ELISA) for IL-18
bioassay Secretion of bioactive IL-18 from human keratinocytes after
varying treatments was determined by the ability of human keratinocyte
supernatants to induce IFN-γ secretion from human PBMC. Human
keratinocytes were left untreated or stimulated for 2 h with 10 ng PMA
per ml, 10 ng phorbol 12,13-dibutyrate per ml, 50 ng LPS per ml, DMSO,
or 0.001% DNCB in DMSO. To avoid a carry over of these substances
to PBMC after the 2 h treatment period, human keratinocytes were washed
four times with solution A (pH 7.4) containing 30 mM HEPES-NaOH
buffer, 10 mM glucose, 3 mM KCl, 130 mM NaCl, 1 mM Na2HPO4•7H2O,
and 0.0033 mM phenol red (all from Sigma), and then replenished with
normal keratinocyte growth media. Cells were then cultured for 16 h in
2.5 ml media per 100 mm tissue culture plate. Culture supernatants were
Figure 1. Human keratinocytes constitutively expressed IL-18harvested and 40% of the supernatant (1 ml) was used to treat PBMC.
mRNA. Northern blot analyses of 10 µg total RNA isolated from eitherPBMC used in the bioassay were pre-stimulated for 16 h with concanavalin
(A) human keratinocytes, or (B) HDMEC and HDF using a Klenow filled-A (0.5 mg per ml, Sigma) and then centrifuged and resuspended in RPMI
in 32P-labeled IL-18 cDNA to identify the IL-18 mRNA (upper panels) ormedia with 20% human serum. 1 3 106 cells per ml were used for a 24 h β-actin cDNA to demonstrate even loading (lower panels).(A) Humantreatment with 1 ml of either RPMI media or keratinocyte growth media
keratinocytes that were either untreated (lanes 1 and 4 ) or treated withalone as controls; RPMI media with the appropriate concentration of
PMA (lane 2), LPS (lane 3), DMSO (lane 5) or DNCB (lane 6). (B)rhIL-18 (Research Diagnostics Inc.), rhIL-12 (R&D Systems Inc.,
HDMEC and HDF that were either untreated (lanes 7 and 10) or treatedMinneapolis, MN) or culture supernatants from treated or untreated human
with PMA (lanes 8 and 11) and LPS (lanes 9 and 12). Data are representativekeratinocytes, to bring the final concentration of human serum to 10%. A
of three separate experiments.human IFN-γ-specific ELISA was used to quantitate IFN-γ secreted by
the PBMC in the media, according to the manufacturer’s recommendations
(R&D Systems and Endogen Inc., Woburn, MA) To determine if IFN-γ
secretion was specifically induced by IL-18 in the human keratinocyte
supernatants, neutralizing antibodies to either rhIL-18 (Research
Diagnostics Inc.) or to rhIL-12 (Transduction Labs, Lexington, KY) were
added to human keratinocyte supernatants at the appropriate concentra-
tions and incubated for 30 min at 37°C prior to human keratinocyte
supernatant exposure to PBMC. rhIL-18 or rhIL-12 preincubated, with
or without the neutralizing antibodies, was used as control treatments
of PBMC.
Data processing The autoradiographs of the northern blots and fluoro-
graphs of western blots were scanned on a La Cie flat bed scanner (La Cie
Ltd, Beaverton, OR) utilizing Adobe Photoshop software (Adobe Systems, Figure 2. IL-18 mRNA in human keratinocytes is associated with
Inc., Mountain View, CA). Subsequently, all of the digitized images were polyribosomes. Total RNA isolated from whole cell lysates of untreated
imported into and labeled in Microsoft Power Point (Microsoft Corp., human keratinocytes (5 3 106 cells) was analyzed by northern blot analysis
Redmond, WA) and printed on a high-resolution laser printer. Each to detect presence of IL-18 mRNA in either an aliquot of the lysate that
autoradiograph and fluorograph figure represents a computer-generated was unfractionated (lane 1) or lysates that were fractionated on a 10–60%
image and each is typical of the original data in the context of relative linear sucrose gradient (lanes 2–10). The RNA isolated from either
band and background densities. the unfractionated (Unfx) or the various fractions containing the ribo-
nucleoprotein complexes (RNP) and the polyribosomes associated
RESULTS complexes (polyribosomes) are indicated. Data are representative of three
separate analyses.Human keratinocytes but not HDMEC, HDF, or HM con-
stitutively express IL-18 in vitro The profile of constitutive IL-18 mRNA is associated with polyribosomes in human
and induced IL-18 mRNA expression by cultured HK, HDMEC, keratinocytes To determine if the constitutively expressed IL-18
HDF, and HM was determined. Human keratinocytes displayed a mRNA in human keratinocytes is also being translated into IL-18
robust constitutive IL-18 mRNA expression (Fig 1A). In contrast, protein, we determined the polyribosome profile of IL-18 mRNA
constitutive IL-18 mRNA could not be detected in either HDMEC, in cultured untreated human keratinocytes. As shown in Fig 2,
HDF (Fig 1B) or HM (data not shown). Although previously IL-18 mRNA was found to be associated with polyribosome
implicated in the expression and secretion of bioactive IL-18 in fractions and not within the ribonucleoprotein fraction. Association
various cell types, treatment of human keratinocytes, HDMEC, of IL-18 mRNA with polyribosomes indicates that IL-18 mRNA is
HDF, and HM with PMA and LPS resulted in no change in their actively being translated into IL-18 protein in cultured, unstimulated
respective constitutive IL-18 mRNA levels. In addition, human human keratinocytes.
keratinocytes treated with DNCB had no effect on RNA levels. A
variety of pro-inflammatory cytokines, growth factors, chemokines, PMA, LPS, and DNCB induce human keratinocytes to
secrete IL-18 Western blot analysis of total cellular proteins fromand neuropeptides, including tumor necrosis factor-α, IL-1β, IL-4,
IL-6, IL-8, IL-12, vascular endothelial growth factor, granulocyte human keratinocytes was performed using anti-IL-18 antibodies
(Fig 3A). Lysates from untreated cells as well as cells treated withmacrophage colony-stimulating factor, basic fibroblast growth fac-
tor, transforming growth factor-α, substance P, substance K, and PMA, DMSO, or DNCB displayed constitutive IL-18 protein
expression. These findings corroborate our data demonstratingthe contact sensitizer DNCB failed to induce IL-18 mRNA
expression de novo in HDMEC (data not shown). Thus in the constitutive polyribosome association of IL-18 mRNA in cultured
human keratinocytes. We next determined if IL-18 protein couldhuman skin, human keratinocytes but not HDMEC, HDF, or HM
express constitutive levels of IL-18 mRNA. Moreover, IL-18 be detected in the culture supernatants of human keratinocytes using
immunoprecipitation–western blot analysis. Anti-IL-18 antibodiesexpression was not modulated further in human keratinocytes or
induced de novo in HDMEC, HDF, or HM by pro-inflammatory immunoprecipitated a protein from the culture supernatants of
human keratinocytes that were treated with either PMA, LPS, ormediators including PMA and LPS or the contact sensitizer DNCB.
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Figure 3. IL-18 protein is constitutively expressed and secreted by
human keratinocytes after treatment with PMA, LPS, or DNCB.
Total protein from human keratinocyte lysates (A) or immunoprecipitated
proteins from culture supernatants of THP.1, HK, and HDMEC using
anti-IL-18 antibodies (B) were separated by sodium dodecyl sulfate–
polyacrylamide gel electrophoresis and specific proteins were detected by
chemiluminescence as described in methods. IL-18, actin, and the molecular
weight markers are indicated. These data are representative of three
different experiments. (A) Western blot analysis of IL-18 protein in human
keratinocyte lysates. Immunodetection of IL-18 protein (upper panel) and
actin (lower panel) as an internal control is shown. Each lane was loaded
with 50 µg of total proteins from human keratinocytes that were either
untreated (lane 1) or treated with PMA (lane 2), DMSO (lane 3), or DNCB
(lane 4) and subjected to western blot analysis. (B) IP/western blot analysis
of IL-18 protein from THP.1, HK, and HDMEC supernatants. Two
micrograms per milliliter of anti-IL-18 antibodies were used to Figure 4. Recombinant human IL-18 and a factor in treated human
immunoprecipitate proteins from 2.5 ml culture supernatants of THP.1 keratinocyte conditioned media induce IFN-g expression by human
(lanes 1 and 2), HK (lanes 3–7), and HDMEC (lanes 8–12) that were either PBMC. (A) rhIL-18 induces IFN-γ production by human PBMC in a
untreated (lanes 1, 3, and 8) or treated with DMSO (lanes 4 and 9), DNCB concentration-dependent fashion. IFN-γ-specific ELISA was performed to
(lanes 5 and 10), LPS (lanes 6 and 11), or PMA (lanes 2, 7, and 12). detect production of IFN-γ by human PBMC that were either untreated
Immunoprecipitated proteins were then subjected to western blot analysis (lane 1) or treated rhIL-18 for 24 h as follows: 1 ng per ml (lane 2); 10 ng
for detection of IL-18 protein. per ml (lane 3); 100 ng per ml (lane 4), and 1000 ng per ml (lane 5). Values
are expressed as pg per ml of IFN-γ produced by PBMC and represent
the mean6SD of triplicate analyses. (B) Selected human keratinocyte
conditioned media induce IFN-γ production by human PBMC. ELISADNCB, but no IL-18 protein was detected in the supernatants of
for IFN-γ expression was performed on normal keratinocyte media (KGM)untreated or DMSO-treated human keratinocytes (Fig 3B). The
or human keratinocyte culture supernatants (CS) prior to exposure tohuman keratinocyte secreted protein co-migrated with IL-18 PBMC (left panel: –PBMC) or on CS after treatment of PBMC with
secreted from THP.1 cells upon treatment with PMA (Fig 3B, selected human keratinocyte conditioned media for 24 h (right panel:
lane 2) at the expected molecular weight (µ18.8 kDa). THP.1 cells 1PBMC). ELISA results performed without PBMC (left panel) to determine
have been previously shown to secrete IL-18 after PMA stimulation whether human keratinocytes themselves secrete IFN-γ are displayed as
(Akita et al, 1997). As expected, anti-IL-18 antibodies failed to follows: lane 1, KGM; lane 2, human keratinocyte CS after treatment with
IL-18 (10 ng per ml); lane 3, human keratinocyte CS after treatment withimmunoprecipitate this protein from the culture supernatants of
PMA (10 ng per ml). ELISA results on PBMC supernatants (right panel )either treated or untreated HDMEC (Fig 3B, lanes 8–12) as these
after treatment of PBMC with human keratinocyte CS are displayed ascells do not express IL-18 mRNA constitutively or after stimulation.
follows: lane 4, untreated human keratinocyte CS; lane 5, PMA (10 ng perUse of an irrelevant first step antibody for immunoprecipitation or
ml for 16 h) treated human keratinocyte CS; lane 6, LPS (10 ng per ml)second step antibody for western blot failed to detect any proteins. treated human keratinocyte CS; lane 7, DNCB (0.001%) treated human
These results indicate that, although human keratinocytes express keratinocyte CS; lane 8, DMSO treated human keratinocyte CS. Values of
IL-18 mRNA and protein constitutively, they secrete immunode- detected IFN-γ are expressed as pg per ml as determined by internal
tectable IL-18 into the culture supernatants only when treated with rhIFN-γ standards and represent the mean6SD of triplicate analyses.
inflammatory mediators such as PMA, LPS, and the contact
sensitizer DNCB.
concentration-dependent manner by secreting IFN-γ (Fig 4A).
Next, we determined whether IFN-γ was present in the growthHuman keratinocytes secrete a factor that induces IFN-g
production by human PBMC In order to address whether the medium or whether treatment of human keratinocytes by either
rhIL-18 or PMA resulted in the secretion of IFN-γ into the humanimmunodetected IL-18 protein secreted in the culture supernatants
of treated human keratinocytes was bioactive and capable of keratinocyte culture supernatant. As shown in Fig 4(B) (lanes 1–3),
no IFN-γ was detected in either untreated or treated humaninducing IFN-γ production by human PBMC, we first confirmed
that concanavalin A-stimulated PBMC responded to rhIL-18 in a keratinocyte supernatants prior to supernatant exposure to PBMC.
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IL-18 antibodies did not cross-react with IL-12 that could poten-
tially be present in the supernatant. These data confirm the
specificity of the neutralizing effect of anti-IL-18 antibodies
observed and demonstrate that the IFN-γ-inducing factor secreted
by human keratinocytes upon PMA treatment is indeed IL-18.
IL-18 is expressed in vivo in the skin In vivo expression of
IL-18 in normal human and psoriatic skin was determined using
immunohistochemical techniques. IL-18 expression in normal skin
(Fig 6A) was restricted to basal and a few suprabasal keratinocytes
and co-localized with ICE expression, whereas control serum failed
to show any staining. In contrast, IL-18 expression in psoriatic skin
(Fig 6B) was seen predominantly in suprabasal keratinocytes. Again
expression of ICE co-localized with IL-18, whereas control serum
failed to show any staining.
DISCUSSION
Inflammation is a crucial component of the immediate, non-
specific immune response to injury or infection, but uncontrolled
inflammation results in pathologies such as psoriasis and arthritis.
The inflammatory profile of many skin diseases is due in part to T
cell production of pro-inflammatory cytokines such as IFN-γ
(Wood et al, 1992; Breathnach, 1993). IFN-γ has wide-ranging
immunomodulatory effects, including the promotion of macro-
phage activation, the induction of major histocompatibility complex
class II and adhesion molecule expression, and the promotion ofFigure 5. Anti-hIL-18 but not anti-hIL-12 antibodies neutralize the
Th1 and the suppression of Th2-mediated immune responses. InIFN-g-inducing factor secreted by human keratinocytes. IFN-γ-
addition, IFN-γ functions as a priming signal for the induction ofspecific ELISA was performed to assess the ability of neutralizing antibodies
to IL-18 and IL-12 to abrogate the ability of human keratinocyte CS and nitric oxide synthase by endothelial cells (Farrar and Schreiber,
rhIL-18 to induce IFN-γ expression by PBMC. PBMC were exposed for 1993) and acts synergistically with other pro-inflammatory cytokines
24 h to rhIL-18 and either untreated or PMA-treated (10 ng per ml) such as tumor necrosis factor-α and numerous interleukins.
human keratinocyte CS as indicated below. rhIL-18 and human keratinocyte As an IFN-γ-inducing factor, IL-18 is emerging as an important
CS were incubated with neutralizing anti-IL-18 antibodies (8 µg per ml) pro-inflammatory cytokine in localized inflammatory and immuno-or anti-IL-12 antibodies (1 µg per ml) for 30 min at 37°C prior to addition logic diseases. Mice treated with anti-IL-18 receptor antibodiesto PBMC. Variable treatments of PBMC with CS, rhIL-18, and antibodies
have decreased Th1 responses and mice deficient in IL-18 haveare displayed in tabulated form above the ELISA data and are as follows:
defective Th1 responses (Takeda et al, 1998; Xu et al, 1998). Thelane 1, untreated; lanes 2–4, rhIL-18 (100 ng per ml); lanes 3 and 7, anti-
persistent expression of IL-18 receptor on Th1 cells emphasizes itsIL-18 antibody; lanes 4 and 8, anti-IL-12 antibodies; lane 5, untreated
human keratinocyte CS; lanes 6–8, PMA-treated (10 ng per ml) human importance in the development and perhaps the maintenance of
keratinocyte CS. Values of detected IFN-γ are expressed as pg per ml as Th1 functions, making it a potential target for clinical intervention
determined by internal rhIFN-γ standards and represent the mean6SD of (Dinarello et al, 1998; Xu et al, 1998).
triplicate analyses. We have shown that among the non-hematopoietic cells of the
human skin, including human keratinocytes, HDMEC, HDF, and
HM, IL-18 mRNA is expressed constitutively and only by humanThese data eliminate the possibility of IFN-γ production by human
keratinocytes. We have demonstrated that pro-inflammatory sub-keratinocytes themselves. IFN-γ was induced and expressed by
stances, such as PMA and LPS, do not further modulate the IL-18PBMC when treated with culture supernatants from human
mRNA levels in human keratinocytes nor induce IL-18 mRNAkeratinocytes that were either treated with PMA, LPS, DNCB
expression de novo in HDMEC, HDF, or HM. The contact sensitizer(Fig 4B, lanes 5–7), or phorbol 12,13-dibutyrate (data not shown).
DNCB also did not affect mRNA levels in human keratinocytes.The magnitude of IFN-γ induction by PBMC after exposure to
We have demonstrated that human keratinocytes constitutivelytreated human keratinocyte supernatants was similar to that induced
translate mRNA into protein, but do not secrete immunoprecipit-by rhIL-18. Moreover, the culture supernatants from untreated
able IL-18 protein into the culture supernatant until exposure toor DMSO-treated human keratinocytes failed to induce IFN-γ
pro-inflammatory agents such as PMA and LPS or the contactproduction by PBMC (Fig 4B, lanes 4 and 8) These results indicate
sensitizer DNCB. We have also shown that the culture supernatantsthat the culture supernatants from treated human keratinocytes
from stimulated human keratinocytes specifically induce IFN-γcontain an IFN-γ-inducing factor.
production by PBMC and that this induction is inhibited by
neutralizing anti-hIL-18 antibodies, but not by neutralizing anti-The IFN-g-inducing factor secreted by human keratinocytes
is IL-18 To determine whether the IFN-γ-inducing factor hIL-12 antibodies. Our in vitro findings are buttressed by immuno-
histochemical studies of normal and psoriatic skin, demonstratingsecreted by human keratinocytes was indeed IL-18, we assessed
the ability of IL-18 neutralizing antibodies to abrogate the induction constitutive and upregulated expression, respectively, of IL-18
protein in human epidermis in vivo.of IFN-γ production in PBMC by rhIL-18 or culture supernatants
from human keratinocytes treated with PMA. As shown in Fig It would be premature to extrapolate from our limited DNCB
data that contact sensitizers in general lead to the secretion of5(A) (lanes 3 and 7 ), anti-rhIL-18 antibodies inhibited the induction
of IFN-γ by PBMC that were either treated with the rhIL-18 or IL-18. To date, we have tested additional compounds, including
nickel sulfate, cobalt chloride, and sodium lauryl sulfate and havewith the culture supernatants from PMA-treated human keratino-
cytes. Anti-hIL-12 antibodies, however, failed to inhibit IFN-γ seen no effect on IL-18 secretion by human keratinocytes. Further
studies exploring various dosages and different hapten-generatinginduction by PBMC that were treated with rhIL-18 or the IFN-
γ-inducing factor secreted into the culture supernatants by PMA- sensitizers vs. irritants are under way. Nevertheless, similar to the
ability of urushiol, also a hapten-generating contact sensitizer, totreated human keratinocytes (Fig 5A, lanes 4 and 8). Antibodies
to hIL-12, but not to hIL-18, neutralized rhIL-12-mediated IFN- induce IL-1β secretion by human keratinocytes through ICE
activation (Boehm et al, 1996; Zepter et al, 1996) it is intriguingγ induction by PBMC (data not shown) indicating that anti-
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Figure 6. In vivo expression of IL-18 in
the human skin. Biopsied human skin
sections from (A) normal human skin and
(B) lesional psoriatic skin were subjected
to immunohistochemistry for detection of
in vivo expressed IL-18 and ICE proteins.
(A) Immunodetection of normal human
skin using primary antibodies to: (1) hIL-
18; (2) ICE p20 subunit; and (3) normal
goat serum control. (B) Immunodetection
of skin sections from psoriatic lesional skin
using primary antibodies to: (1) hIL-18; (2)
ICE p20 subunit; and (3) normal goat
serum control. Each panel is representative
of skin biopsies from three normal and
three psoriasis patients.
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